Calliope Research · November 2026

Many state PBM laws beganwith a problem in the state's own pharmacy plan.

A review of PBM reform laws in all fifty states, 2015 to November 2026, set against what each state found when it was the buyer: auditor and comptroller reports, failed procurements, rebate disputes and settlements over its employee health plan and its Medicaid program.

Every finding comes from public records: auditor and comptroller reports, bills and session laws, attorney general and treasurer releases, committee minutes and meeting recordings. Nothing here is a finding about any PBM's conduct.

50states reviewed, PBM laws 2015 to November 2026
32had a problem as a PBM customer on the public record
18then passed a law or binding rule aimed at that same program within five years
5where a sponsor, agency or witness tied the problem to the law on the record
16where the problem was in the state employee or retiree plan
18passed PBM laws with no customer problem found
Why this study

Delaware spent five years on one pharmacy contractand the legislature wrote down how its own committee should buy.

In June 2021 Delaware's State Auditor estimated that the state employee plan could have saved $24.5 million over three fiscal years under its Express Scripts contract if costs had grown at the national rate. CVS took over that July. In August 2025 the governor signed SJR 7, directing the State Employee Benefits Committee to apply nine PBM transparency strategies. That October the committee cancelled its PBM bid: none of the ten PBMs that bid met all 25 minimum requirements. The committee rebid in 2026, voted down its evaluation team's recommendation on October 26, and approved an award 7–4 on November 2. State procurement law keeps the winner's name sealed until the contract is signed.

That sequence made us ask how often it happens: a state learns what its PBM is costing it as a customer, and the legislature acts on that program afterward. We reviewed the PBM laws in every state from 2015 on, then looked for the record of the state as a buyer: auditor and comptroller reports, legislative audits, failed or cancelled procurements, public contract disputes and attorney general settlements over the state's own plans.

Two programs. A state buys pharmacy benefits twice: for its employees and retirees, and through Medicaid. The Medicaid findings came first, mostly in 2018 to 2020, when states measured spread pricing in their managed care plans. The state employee plan findings came later, from 2019 on, and they are still arriving.

01 · The map

In 18 states a problem as a buyer came firstand a law for that program followed.

Dark states had a problem in their own program on the record and then passed a law or binding rule covering that program within five years. Lilac states had a problem but no law aimed at that program followed: the law came first, it covered the commercial market instead, or nothing has passed. Pale states passed PBM laws with no problem as a buyer found.

State PBM laws 2015–2026 against the state's own record as a PBM customerAll 50 states
Problem, then a law for that program · 18Problem, no law aimed at that program · 14Law, no buyer problem found · 18
AlabamaAlaskaArizonaColoradoFloridaGeorgiaIndianaKansasMaineMassachusettsMinnesotaNew JerseyNorth CarolinaNorth DakotaOklahomaPennsylvaniaSouth DakotaTexasWyomingConnecticutMissouriWest VirginiaIllinoisNew MexicoArkansasCaliforniaDelawareHawaiiIowaKentuckyMarylandMichiganMississippiMontanaNew HampshireNew YorkOhioOregonTennesseeUtahVirginiaWashingtonWisconsinNebraskaSouth CarolinaIdahoNevadaVermontLouisianaRhode IslandALAKAZCOFLGAINKSMEMAMNNJNCNDOKPASDTXWYCTMOWVILNMARCADEHIIAKYMDMIMSMTNHNYOHORTNUTVAWAWINESCIDNVVTLARI
ReadMost of the dark states got there through Medicaid. The state employee plan cases are fewer and more recent, and in Delaware, Louisiana, Oklahoma, Utah, Colorado and Georgia the law that followed names the state's own plan.
Medicaid, 2018 to 2020

Measure the spread, then ban it.

Ohio, Kentucky, Virginia, Pennsylvania and Maryland each measured what PBMs kept between what Medicaid plans paid and what pharmacies were paid. Ohio's auditor put it at $224.8 million in one year; Kentucky's report at $123.5 million. Within one to two years most of them banned spread pricing in Medicaid or moved to a single state-contracted PBM.

State employee plans, 2019 on

Audit the contract, then write the next one into law.

Utah's legislative auditor estimated Express Scripts kept about $6 million a year in spread on state plan claims. Louisiana went through a protested award and years of emergency contracts. Oklahoma's attorney general settled with CVS Caremark for $32.1 million over state plan rebates. In each, the law that followed sets terms for the state's own plan.

The law came first

Some problems surfaced after the law passed.

Arkansas banned Medicaid spread pricing in 2019; an exam for its insurance department estimated in 2020 that Express Scripts charged a Medicaid plan about 15 percent more than it paid pharmacies, which Express Scripts disputed. Iowa passed its law in 2025; its auditor reported about $100 million in back-end Medicaid payments to one PBM in 2026. North Carolina's 2025 law cleared the Senate a month before the state plan's rebate dispute with CVS Caremark went public.

No problem found

18 states legislated without one.

New England and much of the Mountain West passed PBM laws with no customer problem on the record. Most of those laws protect pharmacies or regulate the commercial market, and pharmacists were usually the ones pushing for them.

02 · The cases

Nine states, in the orderthe record shows it happened.

Dates are from the source documents. Lilac points are problems the state had as a buyer; navy points are laws and binding rules.

State plan · Delaware

An auditor's estimate, a failed RFP, then a resolution for the state's own committee.

State Employee Benefits Committee · CVS Caremark incumbent since 2021

  1. June 2021State Auditor special report on the Express Scripts contract: the state could have saved an estimated $24.5 million over fiscal 2018–2020 if cost per prescription had grown at the 4.7 percent national rate. It grew 14.3 percent.
  2. July 2021CVS takes over the state plan, under an award the committee approved in December 2020.
  3. August 2025SS1 for SJR 7 directs the committee to apply nine PBM transparency strategies and report back by August 2026.
  4. October 2025PBM RFP cancelled: none of ten bidders met all 25 minimum requirements.
  5. Oct–Nov 2026Rebid. The committee votes down its evaluation team's recommendation, then approves an award 7–4. The winner is sealed until signing.
ReadThe resolution came four years after the audit and the same year the RFP failed. It is aimed at how the state's own committee buys.

Sources: Delaware Auditor of Accounts, June 18, 2021; SEBC minutes October 10, 2025; SS1 for SJR 7 (153rd GA); SEBC agendas and recording, October 26 and November 2, 2026.

State plan · Oklahoma

A $32.1 million rebate settlement, then new rules for buying the next PBM.

HealthChoice · CVS Caremark

  1. September 2025Attorney General announces a $32.1 million settlement with CVS Caremark over rebates allegedly withheld from HealthChoice, 2020–2024.
  2. January 2026SB 1447 filed. As introduced it would bar HealthChoice from contracting with a PBM that had settled or lost a judgment over $4 million in the prior five years.
  3. May 2026SB 1447 becomes law without the Governor's signature, effective November 1: state data ownership, audit rights, rebate pass-through and claim-level reporting for the state plan.
ReadThe bill as filed described the incumbent's settlement without naming it. The enacted version lets the state weigh a bidder's settlements when it scores proposals.

Sources: Oklahoma Attorney General, September 9, 2025; Oklahoma Legislature, SB 1447 (2026).

State plan · Louisiana

A protested award and emergency contracts, then a law for the Office of Group Benefits.

Office of Group Benefits · about 213,000 members

  1. 2020PBM award to CVS Caremark is protested; Express Scripts runs the plan on an emergency contract through 2022.
  2. January 2023Caremark starts. The Legislative Auditor reports 72 pharmacies opted out of its network.
  3. June 2024Act 546 requires OGB's PBM and claims administrators to disclose all non-fee revenue and remit what exceeds a fixed administrative fee.
  4. June 2025Act 474 bans spread pricing and rebate retention statewide from 2027. A bill to bar PBMs from owning pharmacies fails.
  5. September 2025The budget committee approves emergency contracts splitting the plan for 2026: Liviniti for the commercial plans, SilverScript for Medicare.
ReadLouisiana legislated for its own plan first and then for the market. The procurement itself has not run a normal course since 2020.

Sources: Louisiana Legislative Auditor brief, January 2023; Act 546 of 2024 (HB 172); Act 474 of 2025 (HB 264); Joint Legislative Committee on the Budget, September 2025.

State plan · Utah

A legislative audit of the state plan's PBM, then a rebate-reporting law.

Public Employees Health Program · Express Scripts

  1. December 2019Legislative Auditor General estimates Express Scripts kept about $6 million a year in spread on state plan claims and did not give the plan claim-level rebate data. The audit says legislative action may be needed.
  2. March 2020HB 272 requires PBMs to report claim-level rebate data to insurers, including the state plan, for contracts from 2021 on: the remedy the audit described.
ReadThe audit also found the plan had chosen a spread contract on purpose, because the transparent bids cost more at the time.

Sources: Utah Office of the Legislative Auditor General, Report 2019-13; Utah Legislature, HB 272 (2020).

Medicaid · Ohio

$224.8 million in spread in one year, then a single state PBM.

Ohio Medicaid managed care

  1. August 2018Auditor of State: PBMs kept $224.8 million in spread on Medicaid managed care drugs over one year, including $208 million on generics, a 31.4 percent spread. Medicaid moved to end the spread contracts that month.
  2. July 2019HB 166, the state budget, requires a single state-contracted Medicaid PBM. It went live in October 2022.
  3. 2021–2022Attorney General settlements: $88.3 million from Centene over Medicaid pharmacy billing (2021); $15 million from OptumRx over the Bureau of Workers' Compensation (2022), which OptumRx confirmed after first disputing that a deal was final.
ReadOhio is where the Medicaid wave started. The auditor's number became the reference point for other states.

Sources: Ohio Auditor of State, August 2018; Ohio HB 166 (133rd GA); Ohio Attorney General releases, 2021 and 2022.

Medicaid · Kentucky

The legislature asked for the data, then legislated on what it showed.

Kentucky Medicaid managed care

  1. April 2018SB 5 requires PBMs serving Medicaid plans to report aggregate payment data to the state.
  2. February 2019The state's report finds PBMs kept $123.5 million in spread on Medicaid claims in 2018.
  3. March 2020SB 50 requires one pass-through PBM for all Medicaid managed care. MedImpact started in July 2021.
ReadA clean sequence: data law, finding, reform, about a year apart each.

Sources: Kentucky SB 5 (2018) and SB 50 (2020); Cabinet for Health and Family Services report, February 19, 2019.

Medicaid · Maryland

A law ordered the audit; the audit changed the contracts.

Maryland Medicaid managed care

  1. 2019HB 589 orders the Health Department to audit the PBMs used by Medicaid managed care plans.
  2. January 2020The audit finds all nine plans used spread pricing in 2018: plans paid PBMs $690 million, PBMs paid pharmacies $618 million.
  3. 2021The department, citing the audit, requires plans to drop spread pricing and move to pass-through.
ReadThe link is on the record: the department's own report says it used the audit results to end spread pricing.

Sources: Maryland HB 589 (2019); Maryland Department of Health PBM audit report, January 3, 2020.

Medicaid audit, commercial law · Oregon

The sponsor said the law was based on the audit.

Oregon Health Authority and coordinated care organizations

  1. August 2023Secretary of State audit of the Health Authority's oversight of the PBMs used by Medicaid plans, which paid PBMs $767 million for retail drugs in 2021. It recommends annual independent PBM audits.
  2. April 2024HB 4149: PBM licensure, transparency reporting and audit limits. On the House floor the sponsor said the transparency section is based on the audit.
ReadOregon has the clearest on-the-record link in the study. The law it produced regulates the commercial market and pharmacies, not the Medicaid program the audit was about.

Sources: Oregon Secretary of State Audit 2023-25; Oregon HB 4149 (2024) and the sponsor's published floor remarks.

Counter-example · North Carolina

The law passed first; the state plan fixed its PBM through the contract.

State Health Plan · CVS Caremark through 2027

  1. May 2025The SCRIPT Act (SB 479) passes the Senate. Approved in July, it regulates PBMs in the commercial market and tells the State Health Plan's administrator to consider nine terms in future PBM RFPs.
  2. June 2025The Treasurer announces an impasse with CVS Caremark over what the plan says are tens of millions of dollars in rebates owed since 2023.
  3. October 2025Settlement. The Treasurer says the plan secured hundreds of millions of dollars; no figure was published.
  4. July 2026The plan's board selects Blue Cross NC as PBM from 2028.
ReadNorth Carolina's state plan settled its dispute and changed PBMs through procurement. No new law has been aimed at the plan.

Sources: North Carolina Session Law 2025-69; NC Department of State Treasurer releases, June 5 and October 7, 2025; State Health Plan Board, July 2026.

03 · All fifty states

Every state, with the recordbehind its category.

One line per state. The sources for every row are in the study dataset; the method below explains how each state was coded.

Fifty states · PBM laws 2015–2026 · problems as a buyer from state recordsCoded November 5, 2026
StateCategoryProgramLink to the lawRecord
ColoradoProblem, then a law for that programState planOn the recordSponsor said the state plan might get only one bid for its PBM. HB 21-1237 (2021) requires reverse-auction purchasing; MedImpact replaced OptumRx in 2023. Spread ban 2023 (HB 23-1201).
DelawareProblem, then a law for that programState planTiming onlyAuditor estimated the state plan could have saved $24.5M over FY2018-20 under its Express Scripts contract (2021). CVS took over. 2025 RFP: 0 of 10 bidders qualified. SJR 7 (2025) sets nine PBM strategies for the state plan. 2026 award sealed until signing.
FloridaProblem, then a law for that programMedicaidTiming onlyState-commissioned study found $89M+ Medicaid PBM spread (2020). Executive order 2022 ordered PBM audits; SB 1550 (2023).
GeorgiaProblem, then a law for that programState planTiming onlyIndependents used State Health Benefit Plan data to show Caremark paid chains more (2024). SB 198 vetoed 2024; HB 196 (2025) sets an SHBP reimbursement floor. Express Scripts named intended PBM 2026.
IllinoisProblem, then a law for that programMedicaidTiming onlyCentene Medicaid pharmacy settlement $56.7M (2021). Auditor General: weak oversight of Medicaid plan PBMs (2023). Spread ban 2025 (HB 1697).
IndianaProblem, then a law for that programState plan and MedicaidTiming onlyCentene Medicaid settlement $66.5M (2023). Audit of nearly $6.7B in PBM payments across Medicaid and the state plan found guarantees missed (2024). SEA 140 (2025) requires the state plan to run its own PBM or contract for one; rebid 2026.
KansasProblem, then a law for that programState planTiming onlyLegislative Post Audit of state plan PBM controls (2015); state-commissioned audit found CVS Caremark owed ~$1.2M for 2018-19 (2021). Centene Medicaid settlement $27.6M (2021). SB 20 (2026) bans spread pricing and reaches governmental self-funded plans.
KentuckyProblem, then a law for that programMedicaidTiming onlyState report: PBMs kept $123.5M in Medicaid spread in 2018 (Feb 2019). SB 50 (2020) moved Medicaid to one pass-through PBM.
LouisianaProblem, then a law for that programState planTiming onlyOffice of Group Benefits: 2020 award protest and emergency contracts; 72 pharmacies left Caremark's network (2023). Act 546 (2024) requires OGB's PBM and claims administrators to disclose and remit non-fee revenue. Split from Caremark on emergency contracts for 2026.
MarylandProblem, then a law for that programMedicaidOn the recordLaw ordered a Medicaid PBM audit (2019); it found a $72M spread in 2018 (Jan 2020). The state then required plans to drop spread pricing from 2021. State plan moved from Caremark to MedImpact 2025.
MichiganProblem, then a law for that programMedicaidTiming onlyMedicaid dropped spread contracts (2018); a pharmacists' association report estimated at least $64M in spread (2019). PA 279 (2023) requires pass-through for Medicaid plan PBMs.
North DakotaProblem, then a law for that programState plan and MedicaidOn the recordMedicaid Expansion pharmacy moved in-house (2019). State Auditor: OptumRx would not give the state plan its data (2023). HB 1584 (2025) licenses PBMs and covers self-funded plans.
New YorkProblem, then a law for that programState plan and MedicaidOn the recordMedicaid spread ban in the 2019 budget; NYRx carve-out (2023) after the state blamed PBMs for cost growth. Comptroller audits of Caremark on the Empire Plan (2023-26), no law yet on the state plan.
OhioProblem, then a law for that programMedicaidTiming onlyAuditor of State: $224.8M Medicaid PBM spread in one year (2018). HB 166 (2019) required a single Medicaid PBM. AG recovered $15M from OptumRx for the workers' comp bureau and $88.3M from Centene.
OklahomaProblem, then a law for that programState planTiming onlyAG: $32.1M Caremark settlement over HealthChoice rebates, 2020-24 (2025). SB 1447 (2026) sets data, audit and rebate terms for the state plan; as filed it barred PBMs with large recent settlements.
PennsylvaniaProblem, then a law for that programMedicaidTiming onlyAuditor General: Medicaid PBM payments doubled to $2.86B, with spread (2018). Act 120 (2020) banned hidden Medicaid fees. A 2024 audit found $7M in fees kept despite it.
UtahProblem, then a law for that programState planTiming onlyLegislative audit estimated Express Scripts kept ~$6M a year in spread on state plan claims and withheld rebate data (2019). HB 272 (2020) requires claim-level rebate reporting to insurers, including the state plan.
VirginiaProblem, then a law for that programMedicaidTiming onlyState reports: $29.0M Medicaid PBM spread over 18 months (2019). HB 1291 (2020) banned it; 2025 law moves Medicaid to one fiduciary PBM.
AlaskaProblem, no law aimed at that programState plan—PBM registration law 2024 (HB 226). State plan PBM RFP cancelled Aug 2026, all proposals rejected; OptumRx stays pending re-solicitation.
ArkansasProblem, no law aimed at that programMedicaid—Spread ban 2019 (Act 994). Medicaid spread by Express Scripts found after it, 2020-21 ($2.1M). PBM pharmacy-ownership ban 2025 (Act 624), enjoined.
CaliforniaProblem, no law aimed at that programState plan and Medicaid—Auditor: OptumRx overpaid $6M+ on a Medi-Cal plan (2019). CalPERS replaced OptumRx with CVS Caremark (2025). SB 41 (2025) traces to a 2024 bill, not CalPERS.
IowaProblem, no law aimed at that programMedicaid—SF 383 (2025) came first. Auditor then reported ~$100M in back-end Medicaid payments to one PBM, 2019-21 (2026).
MassachusettsProblem, no law aimed at that programMedicaid—Health Policy Commission found MassHealth MCO generic prices above fee-for-service (2019). PBM law 2025 (Ch. 342) is commercial.
MinnesotaProblem, no law aimed at that programMedicaid—PBM licensure 2019. State plan PBM bought by reverse auction under a 2021 statute; the state later said it could not conclude the auction saved money.
MississippiProblem, no law aimed at that programState plan and Medicaid—Centene Medicaid pharmacy settlement $55.5M (2021); Auditor and AG looked at the state plan PBM (2019). PBM reform bills died 2025 and 2026.
North CarolinaProblem, no law aimed at that programState plan—SCRIPT Act (2025) passed the Senate before the state plan's Caremark rebate dispute went public; it asks the plan only to consider nine terms in future PBM RFPs. The plan settled, then picked Blue Cross NC as PBM from 2028.
New JerseyProblem, no law aimed at that programState plan—Court voided the $6.7B OptumRx state plan award (2018). Union says the plan has gone ~8 years without a PBM rebid; governor formed a reform group (Oct 2026). A1502 has passed only the Assembly.
New MexicoProblem, no law aimed at that programState plan and Medicaid—State Auditor examined Medicaid and state plan PBMs and referred them to the AG (2021); Centene paid $13.7M (2022). Contracts fixed administratively; HB 165 (2024) and HB 174 (2025) set pharmacy dispensing fees.
OregonProblem, no law aimed at that programMedicaidOn the recordSecretary of State audit of Medicaid PBM oversight; $767M paid to PBMs for retail drugs in 2021 (2023). HB 4149 (2024) PBM licensure and transparency; its sponsor said the transparency section is based on the audit.
South CarolinaProblem, no law aimed at that programMedicaid—PBM acts 2019 and 2023. Centene Medicaid pharmacy settlement $25.9M came after (2024).
TexasProblem, no law aimed at that programMedicaid—Inspector General: Caremark spread in two Medicaid plans, $6.7M+ (2024). Texas PBM laws are pharmacy-side and not tied to it.
West VirginiaProblem, no law aimed at that programMedicaid—Medicaid pharmacy carved out of managed care (2017) after a ~$30M-a-year cost finding. HB 5430 (2026) puts the state plan PBM under the Insurance Commissioner.
AlabamaLaw, no buyer problem found——Community Pharmacy Relief Act 2025 (SB 252). No own-program problem found.
ArizonaLaw, no buyer problem found——PBM laws 2021, 2023, 2025 are pharmacy-side and licensure. Auditor General has commissioned a special audit of the state plan, due by March 2027.
ConnecticutLaw, no buyer problem found——PBM laws 2018, 2023, 2025. Comptroller publicizes savings, no losses found.
HawaiiLaw, no buyer problem found——PBM law 2017 (Act 44). No own-program problem found.
IdahoLaw, no buyer problem found——Spread ban and rebate pass-through 2024 (HB 596). No own-program problem found.
MaineLaw, no buyer problem found——PBM laws 2019 and 2025. No own-program problem found.
MissouriLaw, no buyer problem found——PBM law 2020 (HB 1682). No own-program problem found.
MontanaLaw, no buyer problem found——PBM laws 2021 and 2025. No own-program problem found.
NebraskaLaw, no buyer problem found——PBM laws 2022 and 2025. No own-program problem found.
New HampshireLaw, no buyer problem found——PBM law 2019. No own-program problem found.
NevadaLaw, no buyer problem found——SB 389 (2025) moves Medicaid to one PBM with no spread pricing by 2030; testimony cited Ohio and Kentucky. State plan audit found routine missed service penalties.
Rhode IslandLaw, no buyer problem found——PBM act 2026. No own-program problem found.
South DakotaLaw, no buyer problem found——PBM licensure 2023 (HB 1135) and 340B laws. No own-program problem found.
TennesseeLaw, no buyer problem found——PBM laws 2021, 2022; FAIR Rx Act (2026) bans PBM-owned pharmacies after an insurance-regulator audit of Caremark. State plan guarantee recoveries are routine.
VermontLaw, no buyer problem found——PBM laws 2022 and 2024. No own-program problem found.
WashingtonLaw, no buyer problem found——PBM laws 2020 and 2024, the second covering the state plans. No own-program problem found.
WisconsinLaw, no buyer problem found——PBM law 2021 (Act 9). State plan has used Navitus since 2018.
WyomingLaw, no buyer problem found——PBM law 2016. No own-program problem found.
04 · What to watch

The next laws are likely to comefrom the state plans now in dispute.

The Medicaid wave has mostly run its course: most states that measured spread pricing have banned it or moved to a single PBM. The open cases now are state employee plans, and their records are public in a way a private employer's are not. A state plan's auditor reports, committee minutes and settlements read like a performance file on its PBM.

For a plan sponsor, consultant or broker, these are the contracts to read before the next renewal. They show what a large buyer could and could not get from its PBM, and what a legislature decided to require afterward.

Open state plan records to followPublic records
  • Delaware. The winner of the state plan PBM award is sealed until the contract is signed. A retiree group has said it will request the proposal, scorecards and price breakdowns once it is, and expects a PBM bill in 2027.
  • New Jersey. A union says the state plan has gone about eight years without a PBM rebid. The governor formed a working group on the plan in October 2026.
  • New York. The Comptroller has issued four audits of CVS Caremark's work on the Empire Plan since 2023. No law has followed yet.
  • Alaska. The state plan PBM RFP was cancelled in August 2026 with all proposals rejected. OptumRx stays in place until the state bids it again.
  • Arizona. The Auditor General has commissioned a special audit of the state employee plan, including its PBM's performance guarantees, due by March 2027.
  • Indiana. The state plan PBM contract went out to bid in March 2026 after a state-commissioned audit of PBM payments. No award has been published.
  • North Carolina and Georgia. Both state plans are leaving CVS Caremark, North Carolina for Blue Cross NC from 2028 and Georgia for Express Scripts.
Method and limits

How the states were codedand what the coding cannot say.

For each state we listed the significant PBM laws passed from 2015 through November 2026 and the problems the state had as a PBM customer in the same window: findings by a state auditor, comptroller or legislative audit office; inspector general audits; attorney general settlements where the state's own plan or Medicaid program was the injured buyer; failed, cancelled or protested PBM procurements; and contract disputes the state made public. Attorney general suits brought on behalf of residents, such as insulin and opioid cases, were excluded. Routine performance-guarantee payments were not counted as problems.

A state is coded problem, then a law for that program when, within five years after the problem, the state passed a law or adopted a binding rule on how it buys or pays for pharmacy benefits in the program that had the problem. Laws that set pharmacy dispensing fees without touching PBM pricing, rebates, data or purchasing do not count. A link is on the record when a bill sponsor, the agency or committee testimony tied the problem to the law; otherwise the sequence is timing only. Sources were collected by web research on November 5, 2026, and the cases above were checked against the primary documents.

  • Absence of a problem means none was found in public records. Some states publish less than others.
  • Timing is not cause. Most of the sequences here are timing only; 5 states have the link on the record (Colorado, Maryland, North Dakota, New York, Oregon).
  • Dollar figures are as the source stated them: findings, estimates, allegations and settlements are labeled as such. Settlements do not include an admission of wrongdoing.
  • Nothing here is a finding about any PBM's conduct.

Read your own plan's pharmacy recordthe way these states read theirs.

Calliope Flow shows what a plan's filings say about its PBM, carrier and broker, and tracks the public pharmacy RFPs and awards that move the market.

CalliopeSales

The study gives you the market.CalliopeSales gives you the approach.

CalliopeSales is Calliope's consulting arm: market strategy and go-to-market work for benefits teams, led by Becca Johnson. Flow is the software. This is the working session on how your firm, your territory and your producers should use it.

  • A read of your niche: the accounts shaped like what you already win, and the RFPs posting in it.
  • The positioning: how to answer the criteria issuers publish with the facts they withhold.
  • A plan for the team: who prospects what, from which signals, on what cadence.
Tell us what you are working onReplies come from Becca, not a sequence

Prefer a calendar? Book a demo. Or email hello@calliopeflow.ai.